Oragenics, Inc. (OGEN)
0.201
-0.15
(-42.59%)
USD |
NYAM |
Nov 13, 16:00
0.2061
+0.01
(+2.54%)
After-Hours: 19:59
Oragenics EPS Diluted (Quarterly) : -0.577 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.577 |
| June 30, 2026 | -0.571 |
| March 31, 2026 | -0.5118 |
| December 31, 2025 | -0.5354 |
| September 30, 2025 | -1.965 |
| June 30, 2025 | -3.105 |
| March 31, 2025 | -0.1217 |
| December 31, 2024 | -7.993 |
| September 30, 2024 | -0.3773 |
| June 30, 2024 | -0.509 |
| March 31, 2024 | -0.701 |
| December 31, 2023 | -4.138 |
| September 30, 2023 | -0.8543 |
| June 30, 2023 | -1.507 |
| March 31, 2023 | -1.405 |
| December 31, 2022 | -0.906 |
| September 30, 2022 | -1.989 |
| June 30, 2022 | -3330.65 |
| March 31, 2022 | -2.366 |
| December 31, 2021 | -1.182 |
| September 30, 2021 | -2.263 |
| June 30, 2021 | -1.976 |
| March 31, 2021 | -3.041 |
| December 31, 2020 | -2.983 |
| September 30, 2020 | -4.522 |
| Date | Value |
|---|---|
| June 30, 2020 | -14.17 |
| March 31, 2020 | -6.748 |
| December 31, 2019 | -4.679 |
| September 30, 2019 | -4.991 |
| June 30, 2019 | -6.253 |
| March 31, 2019 | -6.531 |
| December 31, 2018 | -5.617 |
| September 30, 2018 | -20.96 |
| June 30, 2018 | -22.70 |
| March 31, 2018 | -25.48 |
| December 31, 2017 | -17.78 |
| September 30, 2017 | -25.17 |
| June 30, 2017 | -14.87 |
| March 31, 2017 | -24.00 |
| December 31, 2016 | -30.00 |
| September 30, 2016 | -23.98 |
| June 30, 2016 | -26.45 |
| March 31, 2016 | -900.00 |
| December 31, 2015 | -1080.00 |
| September 30, 2015 | -30.00 |
| June 30, 2015 | -102.00 |
| March 31, 2015 | -24.00 |
| December 31, 2014 | -18.00 |
| September 30, 2014 | -18.00 |
| June 30, 2014 | -30.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Candel Therapeutics, Inc. | -0.2826 |
| ACADIA Pharmaceuticals, Inc. | 0.305 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | -0.0232 |
| Savara, Inc. | -0.1691 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.603M |
| Total Expenses (Quarterly) | 2.603M |
| Enterprise Value | -0.9239M |
| Earnings Yield | -1.09K% |
| Normalized Earnings Yield | -1092.09 |